ArticleThe Journal of international medical research2020

Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.

Chen Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.